LPCAT2 and metabolic dysfunction-associated steatohepatitis: Hall et al demonstrated that increased inflammation, oxidative damage and liver injury in NASH are associated with pronounced changes in membrane AA remodelling, characterised by AA enrichment in pericentral hepatocytes via upregulation of LPCAT2 expression and subsequent release via PLA2 for the generation of pro‐inflammatory HETEs.40